The first was to compare liver related outcomes of mortality, HCC and decompensated events between the low levels of ALT of 30 U/L for men and 19 U/L for women compared to the conventional level of <40 U/L for men or women. This evidence concerns the gene GPT and hepatocellular carcinoma.